Alcohol Use Disorder (AUD) in New Jersey (NJ) Disparity in Treatment

被引:0
|
作者
Yoade, Bolaji [1 ]
Akinbode, Oluwafemi [2 ]
Olatunji, Olubusola [3 ]
Popoola, Olufemi [4 ]
Busari, Oluwatoyin [5 ]
Odenigbo, Nkolika [6 ]
Kogan, Irina [6 ]
Nkemjika, Stanley [6 ]
机构
[1] Regis Coll, Publ Hlth, Weston, MA 02493 USA
[2] Amer Family Care, Family Med, West Orange, NJ USA
[3] North Kentucky Univ, Coll Hlth Sci & Human Serv, Highland Hts, KY USA
[4] Loyola Univ, Neiswanger Inst Bioeth & Healthcare Leadership, Chicago, IL USA
[5] Univ Hosp Cleveland Med Ctr, Case Western Reserve Univ, Psychiat, Cleveland, OH USA
[6] Interfaith Med Ctr, Psychiat & Behav Sci, Brooklyn, NY USA
关键词
treatment; nj; sociodemographic; disparity; alcohol use disorder; COMPLETION; QUALITY;
D O I
10.7759/cureus.43286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alcohol use disorder (AUD) continues to be a threat to public health due to the associated morbidity, mortality, and social and economic impacts. AUD accounts for greater than 85,000 deaths annually in the United States and greater than 1500 deaths annually in New Jersey (NJ). Despite these associated burdens, the treatment of AUD remains unequal among the population, and it is important to identify the factors influencing the disparity in defined population groups such as NJ to drive the appropriate intervention. Data were retrieved from the 2018 Treatment Episode Data Set-Discharges (TEDS-D) of the United States Substance Abuse and Mental Health Services Administration (SAMHSA). Logistic regression analysis was used to predict the odds of receiving treatment based on socioeconomic factors and the type of treatment received. Compared to Asian or Pacific Islanders in NJ, the American Indian [odds ratio, OR=2.12, 95% confidence interval, CI: 1.95-2.31] has the greatest odds of receiving treatment for AUD, followed by the Black or African American [OR=1.70, 95% CI: 1.65-1.75], the Alaska Native [OR=1.67, 95% CI: 1.42-1.96], and then the White [OR=1.31, 95% CI: 1.12-1.52]. Those who are retired or on disability [OR=0.88, 95% CI: 0.820.94] have lower odds of receiving treatment than those on salary or wages. Those with AUD in NJ have a lower odd of receiving detoxification treatment in a 24-h hospital inpatient setting [OR=0.88, 95% CI 0.820.95] and a higher odd of receiving detoxification treatment in a 24-h service, free-standing residential setting when compared to the treatment received in a rehabilitation/hospital (other than detoxification) setting. This study shows that disparity exists in relation to the type of treatment received and the setting of treatment for AUD in NJ in addition to disparity based on the sociodemographic factors.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Acamprosate-an Anti-Craving Drug for Alcohol Use Disorder (AUD) Pharmacotherapy: Plasma Metabolomics Signatures are Associated With Alcohol Craving Intensity and Acamprosate Treatment Response
    Ho, Ming-Fen
    Zhang, Cheng
    Zhang, Lingxin
    Moon, Irene
    Geske, Jennifer
    Choi, Doo-Sup
    Biernacka, Joanna
    Oesterle, Tyler
    Frye, Mark
    Seppala, Marvin
    Li, Hu
    Karpyak, Victor
    Weinshilboum, Richard
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S139 - S140
  • [32] Alcohol use disorder, neuroinflammation, and intake of dietary fibers: a new approach for treatment
    Perez-Reytor, Diliana
    Karahanian, Eduardo
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2023, 49 (03) : 283 - 289
  • [33] Noradrenergic targets for the treatment of alcohol use disorder
    Haass-Koffler, Carolina L.
    Swift, Robert M.
    Leggio, Lorenzo
    PSYCHOPHARMACOLOGY, 2018, 235 (06) : 1625 - 1634
  • [34] Editorial: Baclofen in the Treatment of Alcohol Use Disorder
    de Beaurepaire, Renaud
    Heydtmann, Mathis
    Agabio, Roberta
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [35] Noradrenergic targets for the treatment of alcohol use disorder
    Carolina L. Haass-Koffler
    Robert M. Swift
    Lorenzo Leggio
    Psychopharmacology, 2018, 235 : 1625 - 1634
  • [36] The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder
    Jorgensen, Charlotte H.
    Pedersen, Bolette
    Tonnesen, Hanne
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (10): : 1749 - 1758
  • [37] Kratom Alkaloids for the Treatment of Alcohol Use Disorder
    Das, Joydip
    ACS CHEMICAL NEUROSCIENCE, 2024, 15 (24): : 4352 - 4359
  • [38] Alcohol Use Disorder Treatment: Problems and Solutions
    Koob, George F.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2024, 64 : 255 - 275
  • [39] The Effects of Oxytocin on Comorbid Symptoms of Posttraumatic Stress Disorder (PTSD) and Alcohol Use Disorder (AUD): An Examination of Alcohol Craving, Social Perception, and Fear Potentiated Startle
    Stauffer, Christopher
    Morrison, Tyler
    Leung, David
    Wen, Jin-Hui
    Batki, Steven
    Neylan, Thomas
    O'Donovan, Aoife
    Woolley, Joshua
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S352 - S353
  • [40] Social and cultural determinants of health; understanding the persisting Alcohol Use Disorder (AUD) in the rural populations in central Kenya
    Mungai, Danny
    Midigo, Ronnie
    AIMS PUBLIC HEALTH, 2019, 6 (04): : 600 - 611